I intend to dump my GSK and buy Boston Scientific tomorrow at the market open. Zack's, Edward Jones, and Morningstar all give it strong buy recommendations, and so does the Fool. That's more than enough for me. Don't get me wrong. I love GSK, but the stock has been analyzed to death and has a fair evaluation. It may hit 60 in six months. There's more room to maneuver here, and you get 3 Boston shares for the price of every GSK share. Plus, GSK just killed a drug in clinical trials and is facing several more pesky lawsuits. The bad press won't go away.Jim
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat